기업 윤리적 딜레마 분석

집

AI 프롬프트 목록

철학/종교

윤리적 의사결정 지원

${:__('collect %s',윤리적 의사결정 지원)}$

철학/종교

功利主義와 의무론에 기반한 균형 잡힌 분석을 제공하여 비즈니스의 도덕적 딜레마에 대응하고, 규정 준수 및 인간적인 의사결정을 지원합니다.

프롬프트 내용

복사

Act as a corporate ethics committee to conduct a deep ethical assessment of the following specific business scenario: A major pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Combine the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent to analyze the moral weight of three strategies: concealing information, issuing public warnings, or initiating a recall. Avoid simple right-or-wrong judgments; instead, construct a multi-dimensional evaluation framework including stakeholder impact, legal risks, brand reputation, and social trust. Finally, output an advisory action guide that aims to balance business sustainability with patient welfare, ensuring the decision-making process is transparent and adheres to the highest ethical standards.

복사

기업 윤리 위원회 역할을 수행하여 다음 구체적인 비즈니스 시나리오에 대한 심층적인 윤리적 평가를 수행하십시오. 대형 제약 회사가 장기 복용 후 경미하지만 무시할 수 있는 부작용이 있는 베스트셀러 의약품이 발견되었지만, 중단 시 일부 환자의 상태가 악화되는 경우입니다. 공리주의의 최대 다수의 최대 행복 원칙과 환자의 자율성과 정보에 기반한 동의 존중을 요구하는 의무론적 요구를 결합하여, 정보 은폐, 대중 경고, 리콜 시작이라는 세 가지 전략의 도덕적 무게를 분석하십시오. 단순한 옳고 그름 판단을 피하고, 이해 관계자의 영향, 법적 위험, 브랜드 평판, 사회적 신뢰를 포함하는 다차원 평가 프레임워크를 구축한 후, 최종적으로 비즈니스의 지속 가능성과 환자 복지의 균형을 맞추는 권고 사항이 포함된 행동 가이드를 출력하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-fatal side effects with long-term use, yet a recall would bankrupt the company and lay off thousands. Evaluate the ethical weights of recalling versus not recalling by combining utilitarian calculations for the greatest good with deontological respect for human dignity, and provide a specific action plan that balances social responsibility with corporate survival, focusing on how to build public trust through transparent communication.

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the moral dilemma in the following business scenario: A pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Please weigh the benefits of disclosure against the risks of concealment, combining utilitarian consequence assessment with deontological respect for informed consent. Finally, provide a specific action plan that balances patient safety, corporate reputation, and legal compliance, focusing on how to maintain trust through transparent communication while minimizing potential harm.

윤리적 의사결정 지원

Act as a corporate ethics consultant to conduct a deep moral deduction on the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but irreversible neurological side effects with long-term use, yet stopping medication carries higher risks and alternative therapies are less effective. Please analyze the ethical weight of four strategies—disclosing information, adjusting pricing, reformulating, or withdrawing from the market—by balancing utilitarian calculations for the greatest good against deontological adherence to patient知情权 and non-maleficence. Provide a final action recommendation that balances business sustainability with social responsibility, focusing on how to build trust through transparency and patient safety.

윤리적 의사결정 지원

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its long-listed common drug may cause severe side effects in a very small group of patients with specific genetic profiles, but the recall cost is extremely high and could lead to drug shortages affecting the majority of patients. Please evaluate the moral rationality of three options—full recall, partial recall, or continued sales—by combining the utilitarian principle of maximizing happiness with the deontological obligation to respect individual rights and the duty of honest disclosure. Provide the best course of action that balances the interests of all parties and aligns with corporate social responsibility, focusing on the ethical trade-off logic in the decision-making process.

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but predictable side effects with long-term use, yet stopping production would leave millions of dependent patients without basic treatment. Please evaluate whether the drug should be voluntarily recalled by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological duty to honestly inform patients of risks. In your analysis, weigh shareholder interests, patient safety, legal compliance, and social trust, and provide a specific action recommendation that balances ethical responsibility with business sustainability, avoiding abstract theoretical stacking and focusing on the practical execution level of ethical trade-offs.

윤리적 의사결정 지원

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks after long-term use, but recalling it will lead to the company's bankruptcy and affect the livelihoods of thousands of employees. Please construct a decision-making recommendation plan that balances business survival and moral obligations, combining the assessment of stakeholder impacts based on utilitarianism with the consideration of the duty of honest disclosure based on deontology. Focus on how to protect patient safety while maintaining sustainable corporate operations, and provide specific communication strategies and execution steps.